What is it about?
This paper describes different statistical experiments showing associations in the temporality of increases in all-cause mortality and covid vaccination campaigns, specifically in Europe in the less than 65 years old.
Featured Image
Why is it important?
Most published covid vaccination follow-up studies are starting their follow-up after a given period (typically 14 days). While this makes sense in order to assess efficacy of treatment, it also raises some questions when it comes to assess the security of it. For the latter matter, one type of publicly available data that can be used is all-cause mortality. In 2021 the all-cause mortality signal in EU spikes. Since the vaccinal status of deceased is still, to our knowledge, publicly unavailable everywhere in Europe, assessing the benefit/risk balance of vaccinations for each age-group from mortality data can be challenging. This paper thus provides several datasets and methods in order to perform such task.
Perspectives
In this paper, one particular age category stands out (through all our statistics) as suffering from what appears as: a defavorable benefit-risk balance, that is the 15-44 years old. When the vaccinal status of deceased will become publicly available, the conclusion suggested in this paper will either be validated or invalidated. However, in the meantime, we believe that the various proposed methods could help other scientists assess age-groups for which the risks may exceed the benefits.
Patrick Meyer
Universite de Liege
Read the Original
This page is a summary of: All-cause Mortality During Covid-19 Vaccinations in European Active Populations, December 2023, ACM (Association for Computing Machinery),
DOI: 10.1145/3638569.3638583.
You can read the full text:
Resources
Contributors
The following have contributed to this page
